Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Arquitos Capital delivered a stellar 29.6% net return in Q2 2025 (66.8% YTD) and is shifting its benchmark to the Russell 2000. The fund remains highly concentrated in high-conviction small-cap value holdings, including Liquidia, ENDI, and Finch Therapeutics.
Full Quick Take
Arquitos Capital delivered a stellar 29.6% net return in Q2 2025 (66.8% YTD) and is shifting its benchmark to the Russell 2000. The fund remains highly concentrated in high-conviction small-cap value holdings, including Liquidia, ENDI, and Finch Therapeutics.
